Wonbiogen Co., Ltd. – Trademark Portfolio

Entity Type: 03

Wonbiogen Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include MEDISORB.

56, 1gongdan-ro 5-gil,

Gumi-si Gyeongsangbuk-do 39372

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MEDISORB
MEDISORB
Abandoned 2024
MEDISORB
MEDISORB
Registered 2023

Trademark Classifications

Wonbiogen Co., Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Wonbiogen Co., Ltd. have?

Wonbiogen Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.

What trademark classes does Wonbiogen Co., Ltd. file in?

Wonbiogen Co., Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are Wonbiogen Co., Ltd.'s most well-known trademarks?

Wonbiogen Co., Ltd.'s registered trademark portfolio includes well-known marks such as MEDISORB. These are among 1 currently registered trademark in the portfolio.

What is Wonbiogen Co., Ltd.'s trademark registration success rate?

Wonbiogen Co., Ltd. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.